CHRISTOPHER M. LINDEMANN,DANIEL J. WATSON,DONALD T. CORSON
申请号：
BR112014009084
公开号：
BR112014009084A2
申请日:
2012.10.12
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
polymorphs of n4- (4 - ([1,2,4] triazolo [1,5-a] pyridin-7-yloxy) -3-methylphenyl) -n6- (4,4-dimethyl-4,5-dihydrooxazole -2-yl) quinazoline-4,6-diamine are provided herein. processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed. Patent polymorphs and pharmaceutical compositions. n- (4 - ([1,2,4] triazolo [1,5-one] pyridin-7-yloxy) -3-methylphenyl) -n6- (4,4-dimethyl-4,5-dihydrooxazole) polymorphs 2-yl) quinazoline-4,6-diamine are provided in this document. Methods for preparing the polymorphs and pharmaceutical composition, comprising the polymorphs are also disclosed.abstract polymorphs of n4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed. tradução do resumo resumo patente de invenção: "polimorfos e composições farmacêuticas". polimorfos da n4-(4-([1,2,4] triazolo [1,5-um] piridin-7-yloxy) -3-metilfenil)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine são fornecidas neste documento. processos para a preparação do polymorphs e composição farmacêutica, compreendendo os polimorfos são também divulgados.
